UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 273

Sortiert nach

Traumatic spinal cord injury in Italy 20 years later: current epidemiological trend and early predictors of rehabilitation outcome

Spinal cord, 2020-07, Vol.58 (7), p.768-777

2020

Link zum Volltext

Verfügbarkeit prüfen

Acute Phase Predictors of 6-Month Functional Outcome in Italian Stroke Patients Eligible for In-Hospital Rehabilitation

American journal of physical medicine & rehabilitation, 2018-07, Vol.97 (7), p.467

2018

Link zum Volltext

Verfügbarkeit prüfen

Impact of acute-phase complications and interventions on 6-month survival after stroke. A prospective observational study

PloS one, 2018-03, Vol.13 (3), p.e0194786-e0194786

2018

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic and Therapeutic Approach to Children and Adolescents with Obstructive Sleep Apnea Syndrome (OSA): Recommendations in Emilia-Romagna Region, Italy

Life (Basel, Switzerland), 2022-05, Vol.12 (5), p.739

2022

Link zum Volltext

Verfügbarkeit prüfen

The costs of drugs used to treat myelodysplastic syndromes following National Comprehensive Cancer Network Guidelines

Journal of the National Comprehensive Cancer Network, 2008-10, Vol.6 (9), p.942

2008

Link zum Volltext

Verfügbarkeit prüfen

Quality indicators in acute stroke care: a prospective observational survey in 13 Italian regions

Aging clinical and experimental research, 2014-06, Vol.26 (3), p.279-286

2014

Link zum Volltext

Verfügbarkeit prüfen

Modeling the Cost-Effectiveness for Cement-Less and Hybrid Prosthesis in Total Hip Replacement in Emilia Romagna, Italy

The Journal of surgical research, 2011-08, Vol.169 (2), p.227-233

2011

Link zum Volltext

Verfügbarkeit prüfen

Variation in the cost of medications for the treatment of colorectal cancer

The American journal of managed care, 2008-11, Vol.14 (11), p.717-725

2008

Link zum Volltext

Verfügbarkeit prüfen

Intermediate care as a solution for managing chronic diseases: The Stroke Care program in Emilia Romagna (Italy)

Italian journal of medicine, 2013-03, Vol.6 (2), p.139-143

2013

Link zum Volltext

Verfügbarkeit prüfen

AdvanTIG-206: Anti-TIGIT monoclonal antibody (mAb) ociperlimab (BGB-A1217; OCI) plus anti-programmed cell death protein-1 (PD-1) mAb tislelizumab (TIS) plus BAT1706 versus TIS plus BAT1706 as first-line (1L) treatment for advanced hepatocellular carcinoma (HCC)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.TPS4172-TPS4172

2022

Link zum Volltext

Verfügbarkeit prüfen

AdvanTIG-206: Anti-TIGIT monoclonal antibody (mAb) ociperlimab (BGB-A1217; OCI) plus anti-programmed cell death protein 1 (PD-1) mAb tislelizumab (TIS) plus BAT1706 versus (vs) TIS plus BAT1706 as first-line treatment for advanced hepatocellular carcinoma (HCC)

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.TPS488-TPS488

2022

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Tolerability of Tremelimumab in Locally Advanced or Metastatic Urothelial Carcinoma Patients Who Have Failed First-Line Platinum-Based Chemotherapy

Clinical cancer research, 2020-01, Vol.26 (1), p.61-70

2020

Link zum Volltext

Verfügbarkeit prüfen

The Impact of Parental Smoking on Asthma and Wheezing

Epidemiology (Cambridge, Mass.), 1999-11, Vol.10 (6), p.692-698

1999

Link zum Volltext

Verfügbarkeit prüfen

Causes and length of stay of readmission among individuals with traumatic spinal cord injury: a prospective observational cohort study

Spinal cord, 2023-07, Vol.61 (7), p.383-390

2023

Link zum Volltext

Verfügbarkeit prüfen

Decompressive craniectomies, facts and fiction: a retrospective analysis of 526 cases

Acta neurochirurgica, 2012-05, Vol.154 (5), p.919-926

2012

Link zum Volltext

Verfügbarkeit prüfen

A phase III, randomized, open label, multicenter, global study of efficacy and safety of durvalumab in combination with gemcitabine+cisplatin (G+C) for neoadjuvant treatment followed by durvalumab alone for adjuvant treatment in muscle-invasive bladder cancer (MIBC) (NIAGARA)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.TPS4592-TPS4592

2019

Link zum Volltext

Verfügbarkeit prüfen

The “Italian Registry of Cardiac Arrest – RIAC”, a National achievement to portrait the Italian reality and to contribute to the wider European vision by “EuReCa”

Resuscitation, 2014-12, Vol.85 (12), p.e193-e194

2014

Link zum Volltext

Verfügbarkeit prüfen

A phase 2, open-label, multicenter study of durvalumab (MEDI4736) ± tremelimumab in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC): ALPS

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.TPS4150-TPS4150

2016

Link zum Volltext

Verfügbarkeit prüfen

Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study

The Lancet. Digital health, 2022-05, Vol.4 (5), p.e359-e369

2022

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and tolerability of tremelimumab in patients with metastatic pancreatic ductal adenocarcinoma

Journal of clinical oncology, 2018-02, Vol.36 (4_suppl), p.470-470

2018

Link zum Volltext

Verfügbarkeit prüfen

A further Rasch study confirms that ALSFRS-R does not conform to fundamental measurement requirements

Amyotrophic lateral sclerosis and frontotemporal degeneration, 2015-08, Vol.16 (5-6), p.331-337

2015

Link zum Volltext

Verfügbarkeit prüfen

A phase 3 study of first-line durvalumab (MEDI4736) ± tremelimumab versus standard of care (SoC) chemotherapy (CT) in patients (pts) with unresectable Stage IV urothelial bladder cancer (UBC): DANUBE

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.TPS4574-TPS4574

2016

Link zum Volltext

Verfügbarkeit prüfen

Epidemiology of amyotrophic lateral sclerosis in Emilia Romagna Region (Italy): A population based study

Amyotrophic lateral sclerosis and frontotemporal degeneration, 2014-06, Vol.15 (3-4), p.262-268

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 273

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(232)
Mit Volltextzugriff
(244)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Traumatic spinal cord injury in Italy 20 years later: current epidemiological trend and early predictors of rehabilitation outcome

Acute Phase Predictors of 6-Month Functional Outcome in Italian Stroke Patients Eligible for In-Hospital Rehabilitation

Impact of acute-phase complications and interventions on 6-month survival after stroke. A prospective observational study

Diagnostic and Therapeutic Approach to Children and Adolescents with Obstructive Sleep Apnea Syndrome (OSA): Recommendations in Emilia-Romagna Region, Italy

Epidemiological, Clinical and Genetic Features of ALS in the Last Decade: A Prospective Population-Based Study in the Emilia Romagna Region of Italy

The costs of drugs used to treat myelodysplastic syndromes following National Comprehensive Cancer Network Guidelines

Quality indicators in acute stroke care: a prospective observational survey in 13 Italian regions

Modeling the Cost-Effectiveness for Cement-Less and Hybrid Prosthesis in Total Hip Replacement in Emilia Romagna, Italy

Variation in the cost of medications for the treatment of colorectal cancer

Intermediate care as a solution for managing chronic diseases: The Stroke Care program in Emilia Romagna (Italy)

AdvanTIG-206: Anti-TIGIT monoclonal antibody (mAb) ociperlimab (BGB-A1217; OCI) plus anti-programmed cell death protein-1 (PD-1) mAb tislelizumab (TIS) plus BAT1706 versus TIS plus BAT1706 as first-line (1L) treatment for advanced hepatocellular carcinoma (HCC)

AdvanTIG-206: Anti-TIGIT monoclonal antibody (mAb) ociperlimab (BGB-A1217; OCI) plus anti-programmed cell death protein 1 (PD-1) mAb tislelizumab (TIS) plus BAT1706 versus (vs) TIS plus BAT1706 as first-line treatment for advanced hepatocellular carcinoma (HCC)

The incidence of narcolepsy in Europe: Before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns

Efficacy and Tolerability of Tremelimumab in Locally Advanced or Metastatic Urothelial Carcinoma Patients Who Have Failed First-Line Platinum-Based Chemotherapy

The Impact of Parental Smoking on Asthma and Wheezing

Causes and length of stay of readmission among individuals with traumatic spinal cord injury: a prospective observational cohort study

Decompressive craniectomies, facts and fiction: a retrospective analysis of 526 cases

A phase III, randomized, open label, multicenter, global study of efficacy and safety of durvalumab in combination with gemcitabine+cisplatin (G+C) for neoadjuvant treatment followed by durvalumab alone for adjuvant treatment in muscle-invasive bladder cancer (MIBC) (NIAGARA)

The “Italian Registry of Cardiac Arrest – RIAC”, a National achievement to portrait the Italian reality and to contribute to the wider European vision by “EuReCa”

A phase 2, open-label, multicenter study of durvalumab (MEDI4736) ± tremelimumab in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC): ALPS

Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study

Efficacy and tolerability of tremelimumab in patients with metastatic pancreatic ductal adenocarcinoma

A further Rasch study confirms that ALSFRS-R does not conform to fundamental measurement requirements

A phase 3 study of first-line durvalumab (MEDI4736) ± tremelimumab versus standard of care (SoC) chemotherapy (CT) in patients (pts) with unresectable Stage IV urothelial bladder cancer (UBC): DANUBE

Epidemiology of amyotrophic lateral sclerosis in Emilia Romagna Region (Italy): A population based study

Suchergebnisse filtern